VueTek Scientific Awarded Innovative Technology Designation from Novation for Veinsite

GRAY, ME, April 15, 2014 (Press-News.org) VueTek Scientific, a global leader in wearable vascular imaging, announced that its Veinsite Vein Imaging Device has been awarded an Innovative Technology designation from Novation - the largest supply chain expertise, analytics and contracting company for the more than 100,000 members of VHA, UHC, Children's Hospital Association and Provista LLC.

Veinsite incorporates near infrared light with the industry's most advanced display configuration to address the ever-increasing clinical challenges of obtaining intravenous (IV) access on difficult venous access (DVA) patients.

The Innovative Technology designation is only provided to a relatively small number of products that are on contract through Novation. Novation works with provider member councils and special task forces to identify and review innovative technology that provides incremental clinical benefit over existing products. Veinsite's new, wearable imaging device has received this designation and will carry the Innovative Technology icon in the Novation contract catalog.

"This award represents yet another win for our vein imaging technology from the leading health care supply chain services and technology company," said Shawn Hong, Director of Sales for VueTek Scientific. "We truly believe that Veinsite's wearable technology will redefine vascular imaging for healthcare professionals and are extremely excited by this opportunity to assist the members served by Novation with their mission to improve patient comfort and outcomes while decreasing unnecessary hospital costs."

Veinsite incorporates a binocular, flat panel display that places the clarity of a liquid crystal display (LCD) in plain view of the user's line of sight. This ensures the highest quality image and largest viewing area of any device in the market. This intuitive design makes it possible for clinicians to have an unobstructed view of the patient while simultaneously seeing through the skin to view patients' veins, bifurcations, identify valves, and observe venous return on the LCD screen, which may not be visible to the unaided eye. Veinsite also allows effortless panning of the patients' entire anatomy during vein assessment with a simple head movement. The biggest benefit of the Veinsite remains that both hands of the clinician are available at all times during the entire vein assessment and venipuncture procedure. This unique design configuration is protected by US and international patents making Veinsite the only device of its kind in the world.

In a recent peer-reviewed, clinical study published in the British Journal of Anaesthesia, Veinsite's efficacy was demonstrated on the most difficult subgroups that included newborn, elderly, obese, morbidly obese and African Americans with dark skin. The study involved 384 subjects, many of whom were classified as 'especially difficult cases' (conventional method detected either no cannulation site or only one). Veinsite increased the detection of possible IV cannulation sites in 97% of especially difficult cases (an 80% - 89% improvement vs. conventional method). On average, researchers saw 3.3 additional IV sites with Veinsite.

About VueTek Scientific
VueTek Scientific, located in Gray, Maine was founded in 2007 to develop and commercialize advanced imaging systems that address unmet clinical needs relating to difficult vascular access in healthcare. For additional information regarding VueTek Scientific or Veinsite Vein Imaging Device, please visit us at www.vuetekscientific.com or call 207-657-6565.

About Novation, Winner of the Ethics Inside Certification
Founded in 1998, Novation is the leading health care supply chain expertise, analytics and contracting company for the more than 100,000 members and affiliates of VHA Inc. and UHC, two national health care alliances, Children's Hospital Association, an alliance of the nation's leading pediatric facilities, and Provista, LLC. Novation provides alliance members with sourcing services, as well as information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 800 suppliers. Members of VHA, UHC, Children's Hospital Association and Provista used Novation contracts to purchase approximately $49 billion in 2013. Novation has earned the coveted Ethics Inside Certification from Ethisphere Institute, a leading international think tank dedicated to the research and promotion of the best practices in corporate ethics and compliance. Novation was also named on Ethisphere's World's Most Ethical Companies list, and is the only company in the health care industry to earn both distinctions for three consecutive years. To learn more about Novation, please follow @NovationNews.